These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6256555)

  • 1. Calcitriol and renal function.
    Christiansen C; Christensen MS; Røbro G
    JAMA; 1981 Feb; 245(5):463-4. PubMed ID: 6256555
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D3 withdrawal in hemodialysis patients with adynamic bone disease.
    Kondo M; Hyodo T; Sakai T
    Nephron; 1998 Sep; 80(1):89. PubMed ID: 9730714
    [No Abstract]   [Full Text] [Related]  

  • 3. Deterioration of renal function in non-dialytic uraemics caused by 1 alpha (OH)D3 which was not attributable to hypercalcaemia.
    Yoshiyama N; Akiba T; Matsui N; Iwamoto H; Ogura M; Nakagawa S; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1980; 17():569-74. PubMed ID: 7243799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dihydrotachysterol treatment in children with chronic renal failure].
    Sieniawska M; Tolloczko I
    Pol Tyg Lek; 1977 Jan; 32(5):181-4. PubMed ID: 834657
    [No Abstract]   [Full Text] [Related]  

  • 6. Rational nursing care in chronic renal disease.
    Lavandero R; Davis V
    Am J Nurs; 1979 Nov; 79(11):1938, 1941. PubMed ID: 258954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in the behavior and control of renal osteodystrophy in patients under chronic hemodialysis].
    Treviño Becerra A
    Gac Med Mex; 1975 Jun; 109(6):411-20. PubMed ID: 1149988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Is it necessary to wait for the time of parathyroidectomy to treat the hyperparathyroidism of patients with chronic renal insufficiency].
    Bernheim J; Faivre JM
    Nouv Presse Med; 1975 Feb; 4(8):591. PubMed ID: 1129122
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
    Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
    Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha-hydroxy derivatives of vitamin D3 and renal function.
    Kanis JA; Cundy T; Naik R
    Lancet; 1978 Aug; 2(8084):316-7. PubMed ID: 79108
    [No Abstract]   [Full Text] [Related]  

  • 11. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hexa-calcium-hexa-sodium-hepta-citrate hydrate complex for prophylaxis and treatment of renal osteopathy in chronic hemodialysis].
    Albert FW; Schmidt U; Schäfer K
    Med Welt; 1973 Feb; 24(5):185-7. PubMed ID: 4805391
    [No Abstract]   [Full Text] [Related]  

  • 14. Disordered divalent ion metabolism in kidney disease: comments on pathogenesis and treatment.
    Brautbar N; Kleeman CR
    Adv Nephrol Necker Hosp; 1979; 8():179-205. PubMed ID: 227253
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiologic vagaries of renal osteodystrophy.
    Vaisrub S
    JAMA; 1973 Jun; 224(13):1755-6. PubMed ID: 4740169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diet in the prevention of uremic osteodystrophy].
    Maschio G; D'Angelo A; Bonucci E; Tessitore N; Lo Schiavo C; Lupo A; Valvo E; Chiaramonte S; Previato G; Fabris A; Saporiti E; Fiaschi E
    G Clin Med; 1980 May; 61(5):358-64. PubMed ID: 7450355
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic value of vitamin D metabolites.
    Robillard JE; Olson DL; Penso JS; Smith FG
    N Engl J Med; 1973 Feb; 288(7):374-5. PubMed ID: 4345569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the locomotor system in renal disease].
    Płachecka-Gutowska M
    Reumatologia; 1979; 17(1):53-9. PubMed ID: 377434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renal osteodystrophy: role of vitamin D and parathyroid hormone].
    Drüeke T; Ulmann A
    Nouv Presse Med; 1979 May; 8(23):1901-3. PubMed ID: 223122
    [No Abstract]   [Full Text] [Related]  

  • 20. Parathyroid function in chronic vitamin D deficiency in man: a model for comparison with chronic renal failure.
    Stanbury SW; Lumb GA
    Calcif Tissue Res; 1976 Aug; 21 Suppl():185-201. PubMed ID: 953806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.